Thierry Guillaume

Immune Reconstitution and Immunotherapy After Autologous Hematopoietic Stem Cell Transplantation

Thierry Guillaume, Daniel B. Rubinstein, Michel Symann · Blood · 1998 · 320 citations

Life Sciences, Hematology, Immunology +14

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis

Alemnew F. Dagnew, Osman İlhan, Won Sik Lee et al. · The Lancet Infectious Diseases · 2019 · 254 citations · Full text

Veterinary Medicine, Immunology, Oncology +16

Receptor for the globular heads of C1q (gC1q‐R, p33, hyaluronan‐binding protein) is preferentially expressed by adenocarcinoma cells

Daniel B. Rubinstein, Alexei Stortchevoi, Michael S. Boosalis et al. · International Journal of Cancer · 2004 · 120 citations

Life Sciences, Immunology, Oncology +17

Zygomycosis after Prolonged Use of Voriconazole in Immunocompromised Patients with Hematologic Disease: Attention Required

S. Vigouroux, Olivier Morin, Philippe Moreau et al. · Clinical Infectious Diseases · 2005 · 120 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome

Thierry Guillaume, Florent Malard, Léonardo Magro et al. · Bone Marrow Transplantation · 2019 · 98 citations

Medicine, Hematology, Oncology +17